Adeona Announces Additional $860,000 Grant For Oral Estriol Multiple Sclerosis Clinical Trial

Links shared publicly online about this topic.

1,466
total visits

Adeona Announces Additional $860,000 Grant For Oral Estriol Multiple Sclerosis Clinical Trial

Adeona Pharmaceuticals, Inc., (AMEX: AEN), a specialty pharmaceutical company dedicated to the awareness, diagnosis, prevention and treatment of zinc deficiency and chronic copper toxicity in the

View full resource at medicalnewstoday.com

Tags: Multiple Sclerosis, Zinc, Pharma, Clinical Trial, Estrogen in the Body, Estriol

Most Recently Shared on January 10, 2010 at 1:04 pm By:

MNT Clinical Trials

Adeona Announces Additional $860,000 Grant For Oral Estriol Multiple Sclerosis Clinical Trial http://mnt.to/3w6j

2 years ago...

Retweet

Favorite

Adeona Multiple Sclerosis Clinical Trial Receives $1.6M Grant « CBS Detroit

detroit.cbslocal.com — “Ann Arbor-based Adeona Pharmaceuticals Inc. announced Tuesday that after a scientific review, the ongoing clinical trial of its Trimesta oral estriol drug for multiple sclerosis has eeceived an additional $1,594,553 in grant funding from the National Institutes of Health's National Institute of Neurological Disorders and Stroke. News, Sports, Weather, Traffic and the Best of Detroit. CBSDetroit.com” View full resource at detroit.cbslocal.com